英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Relapsing-Remitting Multiple Sclerosis | National MS Society
    Multiple sclerosis is an unpredictable disease of the central nervous system that disrupts the flow of information within the brain and between the brain and body Relapsing-remitting multiple sclerosis (RRMS) is the most common course of MS If you have RRMS, you will experience clearly defined relapses of new or increasing neurologic symptoms
  • Treatments for Relapsing MS: How They’re Taken, How Often . . .
    As of 2025, the U S Food and Drug Administration has approved more than 20 disease-modifying therapies (DMTs) for treating relapsing multiple sclerosis (MS) Research shows that DMTs can reduce how often people with MS have flare-ups, also known as relapses or attacks These treatments can also help prevent new damage to the brain and spinal cord Some DMTs may even help slow the progression
  • AAN 2026: Fenebrutinib bests Aubagio for treating relapsing MS
    The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new trial data show
  • 9 approved multiple sclerosis therapies you should know about
    9 Tysabri (Natalizumab) Natalizumab (manufactured by Biogen Idec as Tysabri; previously named Antegren) is a humanized monoclonal antibody approved by the U S Food and Drug Administration (FDA) as a monotherapy for the treatment of relapsing-remitting forms of multiple sclerosis (MS) and Crohn’s disease
  • FDA rejects Sanofi MS drug, Corcept Cushings syndrome therapy
    In secondary progressive MS, patients typically have been diagnosed with relapsing MS but have stopped having relapses and instead experience so-called “disability accumulation ”
  • Relapsing-Remitting Multiple Sclerosis (RRMS): Symptoms . . .
    WebMD explains the symptoms and treatment of relapsing-remitting multiple sclerosis, the most common of the four types of MS
  • What are the new drugs used for multiple sclerosis (MS)?
    MS is a lifelong illness It can follow one of several different patterns: Relapsing-Remitting MS (RRMS) The most common form of multiple sclerosis characterized by temporary periods of relapses and remissions Secondary-Progressive MS (SPMS) Most people who are diagnosed with RRMS will transition to SPMS at some stage
  • Whats New in MS Research - May 2026 | MSAA
    FDA approves Ocrevus ® for pediatric relapsing-remitting MS The Food and Drug Administration (FDA) this month (May 2026) approved Ocrevus ® (ocrelizumab) for the treatment of relapsing-remitting MS in children and adolescents age 10 and older who weigh 55 pounds or more 1 The approval makes the intravenously infused medication only the second disease-modifying therapy (DMT) with an FDA
  • Top 20 Multiple Sclerosis Drugs Market Analysis and Segment . . .
    Top 20 Multiple Sclerosis Drugs: Comparative Market Outlook Through 2030 The multiple sclerosis therapeutics landscape is led by a concentrated group of high-revenue drugs with established market presence and broad indications, especially in relapsing forms of MS and primary progressive MS (PPMS)
  • Genentech: Press Releases | Genentechs Fenebrutinib Confirms . . .
    Approximately 85% of people with multiple sclerosis are initially diagnosed with relapsing-remitting multiple sclerosis (RRMS) Relapsing forms of the disease (RMS) include RRMS and active secondary progressive MS, and people with RMS experience relapses and worsening disability over time





中文字典-英文字典  2005-2009